Evidence map›Paper›PMID 36288002›Full record

ArticleTropical medicine and infectious disease2022

SARS-CoV-2 Infections in a High-Risk Migratory Population Arriving to a Migrant House along the US-Mexico Border.

Nadia A Fernández-Santos, Gabriel L Hamer, Edith G Garrido-Lozada, Mario A Rodríguez-Pérez

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nadia A Fernández-SantosInstituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa 88710, Mexico.
Gabriel L HamerDepartment of Entomology, Texas A&M University, College Station, TX 77843, USA.
Edith G Garrido-LozadaDaughters of Charity of Saint Vincent de Paul (La Casa del Migrante), Reynosa 88520, Mexico.
Mario A Rodríguez-PérezInstituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa 88710, Mexico.

Funding

Instituto Politécnico Nacional 20210581, 20220163, and 20220299Texas A&M University APC (Dr. Gabriel L. Hamer)
6 · The paper itself

Abstract

Few reports exist on the COVID-19 epidemiology of migrant populations. We tested 370 migratory individuals from ten countries arriving at a migrant house along the US-Mexico border based on a rapid assay detecting SARS-CoV-2 antigen. Fifty-six were positive, for a prevalence of 15.1% (95%-CIs of 11.8-19.2%). Only 21 positive persons presented signs or symptoms associated with the infection (95%-CIs = 25-49%). Most (51.7%) positive migrants arrived in the previous two days before being tested, indicating that the virus infection was acquired during their transit. Out of the total of 56 positive individuals, 37.5% were from El Salvador, 33.9% from Honduras, and 21.4% from Guatemala. This study suggests that vulnerable populations traveling from countries in Latin America and seeking residence in the US are high-risk individuals for exposure to SARS-CoV-2. The rapid antigen COVID-19 testing on arrival at the migrant house, and subsequent 10-day quarantine, was a critical step to help minimize further transmission. Therefore, the present study demonstrates that public health services provided to migratory and vulnerable populations are necessary for pandemic control.

Indexed as

COVID-19infectious diseasesMéxicomigrantspreventionSARS-CoV-2

Identifiers

PMID36288002
PMCPMC9607274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.